Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V for medicinal products (open-house procedure)
Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren)
Germany
Contract
BuyerAOK Baden-Württemberg
TypeSupplies
Estimated valuevalue not published
Published23 July 2026
CategoryMedical equipment & pharma · CPV 33000000
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Hexal AG · Holzkirchen | 17 | 2017–2025 |
| Novartis Pharma GmbH · Nürnberg | 15 | 2013–2025 |
| Bayer Vital GmbH · Leverkusen | 14 | 2013–2025 |
| Janssen-Cilag GmbH · Neuss | 13 | 2014–2026 |
| Zentiva Pharma GmbH · Frankfurt am Main | 13 | 2021–2026 |
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.
How often this buyer tenders this
201942
202026
202139
202227
202332
202482
20252
2025112
202638
Who knows the rhythm prepares instead of reacting.
1
days until the deadline — Thursday 20 August at 19:59
How to bid
Read the full notice — Original + documents
Goes directly to this tender on Vergabemarktplatz (cosinex). The full specification and all annexes are there.
Tenders like this, every morning at 7:30 in your inbox.
Start free →